Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Presenter: John Connolly

October 28, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Presentation TCT 2024

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Kazuki Suruga

October 27, 2024

Presentation TCT 2024

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

Presenter: Prakash Upreti

October 27, 2024

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

Presentation TCT 2020

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

Presenter: Jaffar Khan

October 14, 2020

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

Presenter: Toby Rogers

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

Presentation TCT 2018

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Presentation TCT 2017

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

Conclusions and Take-home Messages

Presenter: Dariusz Dudek, Martin Hudec

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Conclusion - How I Treated This Case

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Advertisement

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

The Clinical Evidence: Extreme- to Low-Risk Patients

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

The NOTION 2 Low-risk Trial in Younger Patients

The Evolut R Low-risk Trial

The PARTNER 3 Low-risk Trial

Conclusions and Take-home Messages

Germany Presents: Case Conclusion - How I Treated This Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content